Details

NameSymbolSector
COHANCE LIFESCIENCES LIMITEDCOHANCEPharmaceuticals
Open
970
High
979.85
Low
899
Close
913.85
Volume
879027
Exchange
nse
Time
14/08

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Cohance Lifesciences is  
Normal
Estimated Stoploss of Cohance Lifesciences is ₹  
979.85
Cohance Lifesciences has a  
Bearishℹ
 pattern. 
Formation of  
Normal
 candle pattern indicates the trend direction of Cohance Lifesciences is  
Unpredictableℹ
. 

Trend

Cohance Lifesciences is in  
Strong Downtrendℹ
. 
Price of Cohance Lifesciences is  
Downℹ
 by  

8.39

%. 
Target
Buy @ 

910.75

Sell @ 

999.65

Volume

The trades of Cohance Lifesciences have been in  
Immenseℹ
 volume. 
The volume trades for Cohance Lifesciences are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Cohance Lifesciences is  

Up

 by  

260.16

% 

Valuation

The current market price of Cohance Lifesciences is  
Overvaluedℹ

Financials

Balance
The balance sheet of Cohance Lifesciences is:  

Balanced

Cashflow
Cohance Lifesciences has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 38cr

. It is  
Upℹ
 by  

323.53

%. 

(*Mar 2025)

52.65% i.e. ₹ 288cr earned in operatingℹ
46.62% i.e. ₹ 255cr spent in investingℹ
0.55% i.e. ₹ 3cr earned in financingℹ
0.18% i.e. ₹ 1cr earned in otherℹ
Cohance Lifesciences has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 17cr

. It is  
Downℹ
 by  

185

%. 

(*Mar 2024)

48.84% i.e. ₹ 358cr earned in operatingℹ
49.39% i.e. ₹ 362cr spent in investingℹ
1.77% i.e. ₹ 13cr spent in financingℹ
0% in otherℹ
Income
The income of Cohance Lifesciences is  

₹ 563cr

 and  

Profit

 is :  

₹ 46cr

(*Jun 2025)

Cohance Lifesciences Profit is up by:  

21.05

% and Income is Up by:  

36.65

% 

(*Jun 2025)

The income of Cohance Lifesciences is  

₹ 412cr

 and  

Profit

 is :  

₹ 38cr

(*Mar 2025)

Cohance Lifesciences Profit is down by:  

54.22

% and Income is Up by:  

27.95

% 

(*Mar 2025)

The income of Cohance Lifesciences is  

₹ 322cr

 and  

Profit

 is :  

₹ 83cr

(*Dec 2024)

Cohance Lifesciences Profit is up by:  

2.47

% and Income is Up by:  

18.82

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.